Real-World data may reveal Pluvicto's true impact on advanced prostate cancer survival
NCT ID NCT07697989
First seen Jul 13, 2026 · Last updated Jul 23, 2026 · Updated 3 times
Summary
This study looks at how effective the drug Pluvicto (177Lu-PSMA-617) is in treating men with a type of advanced prostate cancer that no longer responds to hormone therapy and has spread to other parts of the body. Researchers will analyze medical records from over 1,000 patients in the United States and Germany to measure survival times and other outcomes. The goal is to see how well the drug works outside of controlled clinical trials, in everyday medical practice.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Pluvicto (177Lu-PSMA-617)
- What this could lead to
- If successful, this study could confirm that Pluvicto improves survival in a broad, real-world population of men with advanced prostate cancer, supporting its use in routine care.
- What could go wrong
- This is an observational study, not a controlled trial, so results may be influenced by patient selection or other treatments. Effectiveness may vary across different patient groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CASTRATION RESISTANT PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a blast of testosterone shrink hard-to-treat prostate cancer?
- Can a Two-Drug attack stall resistant prostate cancer?
- A PET scan and a blood test may predict which men with advanced prostate cancer will benefit from targeted therapy
- Can a new daily pill slow advanced prostate cancer?
- Can a new pill slow advanced breast cancer better than standard hormone therapy?
- Radiation plus hormone therapy may slow resistant prostate cancer